MRL Ventures Fund Investor

MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.

Founded Date: 2014-01-01
Last Funding Type: Series A
Headquarters: Cambridge, Massachusetts, United States
Employee Number: 1-10
Industry: Biomarkers Discovery
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-05-23
Number Of Exists: 11
Funding Status: Series A
Investor Type: Corporate Venture Capital, Venture Capital
Investment Stage: Convertible Note, Early Stage Venture, Seed, Venture
Total Funding: 18735034